Drawing for MYARTA

USPTO serial 79220174

MYARTA

Reviewed by CopyMark Law Group

Reg. 5592422Status 404
Filing date
Status date
Registration date
Oct 30, 2018
Examiner
LEE-RICHARDSON HA, BRITTANY NICOLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYARTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, immune system, cardiovascular system, metabolic system, endocrine system, respiratory system, musculoskeletal system and genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular diseases and disorders, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infectious, antiviral and antibiotic preparationsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 17, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 4, 2022GPNXNOTIFICATION PROCESSED BY IB—
Nov 23, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 27, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jun 27, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 22, 2019FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 7, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 7, 2019FIMPFINAL DISPOSITION PROCESSED—
Jan 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 30, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 14, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 25, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 25, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 25, 2018NPUBNOTICE OF PUBLICATION—
Jul 12, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 2, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 27, 2018ALIEASSIGNED TO LIE—
Feb 5, 2018DOCKASSIGNED TO EXAMINER—
Jan 19, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 17, 2017RFRRREFUSAL PROCESSED BY MPU—
Dec 7, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 6, 2017CNSLSUSPENSION LETTER WRITTEN—
Nov 29, 2017RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Nov 15, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 14, 2017CNSLSUSPENSION LETTER WRITTEN—
Nov 11, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2017DOCKASSIGNED TO EXAMINER—
Nov 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 2, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance